___

Gürsoy A, Demirayak Ş, Cesur Z, Reisch J, Ötük G. Synthesis of some hydrazide-hydrazones, thiosemicarbazides, thiadiazoles, triazoles and their derivatives as possible antimicrobiales. Pharmazie 1990; 45: 246-50.

Çapan G, Ulusoy N, Ergenç N, Kiraz M. New 6-phenylimidazo[2,1-b]thiazole derivatives: Synthesis and antifungal activity. Monatsh Chem 1999; 130: 1399-1407.

Gürsoy E, Ulusoy Güzeldemirci N. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 2007; 42: 320-6.

Harraga S, Nicod L, Drouhin JP, Xicluna A, Panouse JJ, Seilles E, Robert JF. Imidazo[2,1-b]thiazole derivatives. XI. Modulation of the CD2-receptor of human T trypsinized lymphocytes by several imidazo[2,1-b]thiazoles. Eur J Med Chem 994; 29: 309-15.

Robert JF, Xicluna A, Panouse JJ. Advances in heterocyclic chemistry. Eur J Med Chem Chim Ther 1975; 10: 59-64.

Inderlied CB, Nash KA. Antimycobacterial Agents: In Vitro Susceptibility Testing and Mechanisms of Action and Resistance. In: Antibiotics in Laboratory Medicine. 5th ed. Editor: Lorian V. Lippincott-Williams & Wilkins, Philadelphia. 2005, p. 155.

Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004-9.

Kühmstedt H, Kottke K, Knoke D, Robert JF, Panouse JJ. Synthesis of amides and heterocyclic acylhydrazides with potential immunomodulator properties. Ann Pharm Fr 1983; 40: 425-9.

Robert JF, Boukraa S, Panouse JJ, Loppinet V, Chaumont JP. Dérivés de l’imidazo[2,1-b]thiazole X. Propriétés fongistatiques de 2-aminothiazoles et de 6-aryl imidazo[2,1-b] thiazoles s ubstitués respectivement en 4 et en 3 par un reste aryléthyle, aroylméthyle, β-hydroxy β-aryléthyle et et éthoxycarbonylméthyle. Eur J Med Chem 1990; 25: 731-6.

Ulusoy N, Küçükbasmacı Ö. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem 2010; 45: 63-8.

Ulusoy N, Kiraz M, Küçükbasmacı Ö. New 6-(4-bromophenyl)imidazo[2, 1- b] thiazole derivatives: Synthesis and antimicrobial activity. Monatsh Chem 2002; 133: 1305-15.

Ulusoy, N. Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4- aza-1-thiaspiro[4.5] decan-3-one derivatives of imidazo[2, 1- b] thiazole. Arzneim- Forsch/Drug Res 2002; 52: 565-71.

Ulusoy N, Çapan G, Ötük G, Kiraz M. Synthesis and antimicrobial activity of new 6-phenylimidazo[2, 1- b] thiazole derivatives. Boll Chim Farmac 2000; 139: 167-72.

Cui Z, Li Y, Ling Y, Huang J, Cui J, Wang R, Yang X. New class of potent antitumor acylhydrazone derivatives containing furan. Eur J Med Chem 2010; 45: 5576-84.

Küçükgüzel ŞG, Rollas S, Küçükgüzel İ, Kiraz M, Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur J Med Chem 1999; 34: 1093-1100.

Thomas KD, Adhikari AV, Telkar S, Chowdhury IH, Mahmood R, Pal NK, Row G, Sumesh E. Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur J Med Chem 2011; 46: 5283-92.

Chakravarty D, Bose A, Bose S. Synthesis and antitubercular activity of isonicotinoyl and cyanoacetyl hydrazones. J Pharm Sci 1964; 53: 1036-9.

Isler O, Gutmann H, Straub O, Fust B, Böhni E, Studer A. Chemotherapie der experimentellen Tuberkulose III. Derivate des 2-Methyl-isonicotinsäur ehydrazids. Helv Chim Acta 1955; 38: 1046-60.

Sah PPT, Peoples SA. Isonicotinyl hydrazones as antitubercular agents and derivatives for identification of aldehydes and ketones. J Am Pharm Ass Sci Ed 1954; 43: 513–24.

Wang NY, Xu Y, Zuo WQ, Xiao KJ, Liu L, Zeng XX, You XY, Zhang LD, Gao C, Liu ZH, Ye TH, Xia Y, Xiong Y, Song XJ, Lei Q, Peng CT, Tang H, Yang SY, Wei YQ, Yu LT. Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agents. J Med Chem 2015; 58; 2764-78.

Juspin T, Laget M, Terme T, Azas N, Vanelle P. TDAE-assisted synthesis of new imidazo[2, 1- b] thiazole derivatives as antiinfectious agents. Eur J Med Chem 2010; 45: 840-5.

Shetty NS, Khazi IAM, Ahn C. Synthesis, anthelmintic and anti-inflammatory activities of some novel imidazothiazole sulfides and sulfones. Bull Korean Chem Soc 2010; 31: 233740.

Budriesi R, Ioan P, Locatelli A, Cosconati S, Leoni A, Ugenti MP, Andrean i A , D i Toro R, Bedini A, Spampinato S, Marinelli L, Novellino E, Chiarini A. Imidazo[2, 1- b] thiazole system: A scaffold endowing dihydropyridines with selective cardiodepressant activity. J Med Chem 2008; 51: 1592-1600.

Andreani A, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R , R amb aldi M, Roda A. Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2, 1- b] thiazole derivatives. Eur J Med Chem 2005; 40: 1331-4.

Park JH, El-Gamal MI, Lee YS, Oh CH. New imidazo[2, 1- b] thiazole derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies. Eur J Med Chem 2011; 46: 5769-77.

Cesur Z, Güner H, Ötük G. Synthesis and antimycobacterial activity of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 1994; 29: 981-3.

Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M. Synthesis and antitubercular activity of imidazo[2, 1- b] thiazoles. Eur J Med Chem 2001; 36: 743-6.

Remers WA. Antineoplastic Agents. In: Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry. 10th ed. Editors: Delgado JN, Remers WA. Lippincott-Raven, Philadelphia. 1998, p. 391.

Singh MM. XDR-TB-Danger ahead. Indian J Tuberc 2007; 54: 1-2.

Tuberculosis; World Health Organization: Geneva, 2014; http://www.who.int/tb/research/en/.